SEC Form 4 · accession 0001232524-17-000187
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Patrick Miller
Officer — EVP, US Commercial
Period of report
Dec 11, 2017
Accepted (ET)
Dec 13, 2017 · 5:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Dec 11, 2017 | S | 200 | $139.15 | D | 21,869 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2Includes 73 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2017.